Search results
Results From The WOW.Com Content Network
The International AIDS Conference (abbreviated AIDS 2012, AIDS 2014 and so on) is the world's most attended conference on HIV and AIDS, and the largest conference on any global health or development issue in the world. [7] First convened during the peak of the AIDS epidemic in 1985, they were held annually until 1994 when they became biennial.
The Conference on Retroviruses and Opportunistic Infections (CROI) is an annual scientific meeting devoted to the understanding, prevention and treatment of HIV/AIDS and the opportunistic infections associated with AIDS. Thousands of leading researchers and clinicians from around the world convene in a different location in North America each ...
X International AIDS Conference, 1994; XI International AIDS Conference, 1996; XII International AIDS Conference, 1998; XIII International AIDS Conference, 2000; XIV International AIDS Conference, 2002; XV International AIDS Conference, 2004; XVI International AIDS Conference, 2006; XVII International AIDS Conference, 2008; XVIII International ...
In 2016 she was elected President of the International AIDS Society. [21] She gave the opening address at the International AIDS Society Conference in Paris, where she spoke about new prevention options such as Pre-exposure prophylaxis. [22] In 2018 she was elected to the board of the International AIDS Vaccine Initiative. [14]
At the 2024 International AIDS Conference, PrEP with long-acting injectable cabotegravir (CAB-LA; Apretude) appears safe during pregnancy among cisgender women, according to an analysis from the HPTN 084 open-label extension trial. [120]
This was a follow-up to the Barcelona Youthforce. Bangkok youth attendees disbanded Youth Against AIDS after the conference and several young leaders received support from the United Nations Population Fund (UNFPA) and UNAIDS to form the Global Youth Coalition on HIV/AIDS, (GYCA), [4] a global, youth-led network that has now grown to over 6,000 members in 173 countries worldwide.
At the recent 2024 International AIDS Conference in Munich urged Gilead Sciences to allow Lenacapavir to have generic licensing access to the UN-backed Medicines Patent Pool so that whereby cheaper generic versions could be sold under licence in low- and middle-income countries similar to Gilead Sciences existing relationships with the MPP and ...
The conference opened with UN Secretary General Ban Ki-moon pointing out that funding by rich economies for poor countries fighting HIV/AIDS was reduced to 7.6 billion dollars from 7.7 billion dollars in 2008. The countries cut funding because of the Great Recession. Ki-moon stated that "Some governments are cutting back on their response to AIDS.